Loading...

VentriPoint Diagnostics Ltd.

VPTDFPNK
Healthcare
Medical - Devices
$0.11
$0.00(0.00%)

VentriPoint Diagnostics Ltd. (VPTDF) Company Profile & Overview

Explore VentriPoint Diagnostics Ltd.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

VentriPoint Diagnostics Ltd. (VPTDF) Company Profile & Overview

Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.

SectorHealthcare
IndustryMedical - Devices
CEOHugh MacNaught

Contact Information

18 Hook Avenue, Toronto, ON, M6P 1T4

Company Facts

IPO DateSep 22, 2010
CountryCA
Actively Trading

Frequently Asked Questions

;